Dizal to Present ZEGFROVY NSCLC Data at WCLC 2026
SHANGHAI, China, August 21, 2026 Dizal Pharmaceutical announced that emerging clinical data for ZEGFROVY® (sunvozertinib) will be presented at...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
SHANGHAI, China, August 21, 2026 Dizal Pharmaceutical announced that emerging clinical data for ZEGFROVY® (sunvozertinib) will be presented at...
NANJING, China, August 21, 2026 Nanjing Leads Biolabs Co., Ltd. announced that China’s Center for Drug Evaluation (CDE) under...
San Francisco, California, August 20, 2026 Chai Discovery has announced a collaboration with Bristol Myers Squibb (BMS) to advance...
Mumbai, India and Naples, Italy, August 17, 2026 Lupin Limited, a global pharmaceutical company, announced that it has received...
Emeryville, California, August 17, 2026 OmniAb, Inc. has announced a new global collaboration and license agreement with Eli Lilly...
LONDON, July 30, 2026 GSK has announced plans to establish a new global flagship research and development (R&D) centre...
Waltham, Massachusetts, July 28, 2026 Dyne Therapeutics has announced that the U.S. Food and Drug Administration (FDA) has cleared...
Ramat-Gan, Israel, July 28, 2026 Galmed Pharmaceuticals Ltd. has announced a significant advancement in the development of Aramchol orally...
